Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings Corporation

Joint Medical Company provides a comprehensive catalog of medical products and services across the spectrum, from injection syringes to advanced diagnostic instruments and hospital equipment. The company aims to improve medical outcomes and preserve health.

Joint Medical Company

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

NuVasive, Inc.

Sanuwave provides wound care technologies that aim to restore the body's regenerative process with FDA cleared ultrasound systems for pain-free treatment.

Sanuwave

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Life offers a broad portfolio of products and solutions for neurosurgery, wound reconstruction, plastic and reconstructive surgery, and instrumentation and lighting in medical procedures. The company self-describes as a global leader in neurosurgery.

Metric
Company Name	Integra LifeSciences Holdings Corporation	Joint Medical Company	NuVasive, Inc.	Sanuwave
Symbol	IART		NUVA
MSH ID	COM:INTEGRALIFE	COM:JOINTMEDICALKW	COM:NUVASIVE	COM:SANUWAVE
Market	STOCKS	PRIVATE	STOCKS	STOCKS
Sector	Healthcare	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Medical - Devices	Medical Equipment and Supplies	Medical - Devices	Medical Devices
Country	US	KW	US	US
Stage
Employee Count	3.95K		3K
Website	integralife.com	jointmedicalkw.com	nuvasive.com	sanuwave.com
LinkedIn				sanuwave
Founders

Metric
Market Cap	2.31B	2.08B	22.44M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	1.54B	1.20B
Revenue (LTM)
Revenue (NTM)
Gross Profit	888.39M	865.43M
EBITDA	297.59M	211.80M
Operating Income	174.08M	64.77M
Net Income	67.74M	40.41M
EPS	0.85	0.78
Diluted EPS	0.84	0.76
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.67	0.72
Operating Profit Margin	0.09	0.08
EBITDA Margin	0.19	0.18
Net Profit Margin	0.04	0.03
Return on Equity	0.04	0.03
Return on Assets	0.02	0.01
Return on Capital Employed	0.04	0.05

COM:INTEGRALIFE

Integra Life

Last Close

23.00

22/11 21:00

Market Cap

1.68B

Beta: -

Volume Today

549.74K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	32.01	73.24
P/B Ratio	2.04	2.33
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.74	2.24
EV Multiple	16.24	8.48

Metric
Days Sales Outstanding	60.64	79.51
Days Payables Outstanding	53.84	124.79
Days Inventory Outstanding	293.69	480.24
Operating Cycle	351.22	584.96
Cash Conversion Cycle	282.50	422.32
Asset Turnover	0.41	0.59

Metric
Operating Cash Flow	139.96M	169.12M
Free Cash Flow	73.09M	29.69M
Cash Flow to Debt	0.63	0.15
Operating Cash Flow/Sales	0.09	0.11
Free Cash Flow Yield	0.04	-0.00

Metric
Cash & Equivalents	276.40M	248.66M
Accounts Receivable	4.59M	-37.18M
Inventory	389.61M	338.60M
Goodwill	1.06B	639.66M
Debt to Capitalization	0.55	0.50
Debt to Assets	0.28	0.43
Current Ratio	2.89	1.25
Quick Ratio	3.35	0.60

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.02
R&D to Revenue	0.07	0.08
SG&A to Revenue